ArticleCancer research2019

Bcl-2 Is a Therapeutic Target for Hypodiploid B-Lineage Acute Lymphoblastic Leukemia.

Ernesto Diaz-Flores et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.